Colleen Nelson

Q: What Schools Are Affiliated With Colleen Nelson

Colleen Nelson is affiliated with the following schools: Queensland University of Technology, University of British Columbia, University of Melbourne

Colleen Nelson's AcademicInfluence.com Rankings

Colleen Nelson

Biology

#11825

World Rank

#15251

Historical Rank

Biochemistry

#2557

World Rank

#2726

Historical Rank

biology Degrees

Download Badge

Biology

Colleen Nelson's Degrees

PhD Biochemistry University of Melbourne

Why Is Colleen Nelson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor Colleen Nelson is a scientist in prostate cancer research. Professor Nelson founded and directs the Australian Prostate Cancer Research Centre - Queensland . The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. Professor Nelson is also Chair of Prostate Cancer Research at Queensland University of Technology .

(See a Problem?)

Colleen Nelson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. (2008) (772)
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. (2007) (526)
Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? (2005) (404)
Development and application of a salmonid EST database and cDNA microarray: data mining and interspecific hybridization characteristics. (2004) (336)
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells (2005) (277)
Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence (2004) (276)
Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development (2015) (253)
Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. (2000) (249)
Conifer defence against insects: microarray gene expression profiling of Sitka spruce (Picea sitchensis) induced by mechanical wounding or feeding by spruce budworms (Choristoneura occidentalis) or white pine weevils (Pissodes strobi) reveals large-scale changes of the host transcriptome. (2006) (247)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. (2007) (241)
Fish and chips: Various methodologies demonstrate utility of a 16,006-gene salmonid microarray (2005) (230)
Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. (2005) (225)
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. (2000) (222)
miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data (2012) (211)
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. (1999) (201)
PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer (2006) (198)
The Androgen Receptor Can Promote β-Catenin Nuclear Translocation Independently of Adenomatous Polyposis Coli* (2002) (174)
YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activity (2004) (173)
Mechanisms of the development of androgen independence in prostate cancer (2005) (173)
Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration‐resistant prostate cancer in a mouse xenograft model (2010) (169)
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. (2000) (157)
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development. (2013) (156)
Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. (2011) (152)
In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors (2009) (138)
Small interference RNA targeting heat‐shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase‐3 activation in vitro (2006) (135)
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E (2010) (131)
The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer (2014) (117)
Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer Cells (2010) (113)
Functional localization and competition between the androgen receptor and T-cell factor for nuclear β-catenin: a means for inhibition of the Tcf signaling axis (2003) (113)
Insulin increases de novo steroidogenesis in prostate cancer cells. (2011) (112)
Adverse effects of androgen‐deprivation therapy in prostate cancer and their management (2015) (106)
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. (2016) (102)
Polychlorinated biphenyls interfere with androgen-induced transcriptional activation and hormone binding. (2002) (101)
Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides. (1999) (99)
Identification of conserved core xylem gene sets: conifer cDNA microarray development, transcript profiling and computational analyses. (2008) (99)
The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell–cell adhesion and to suppress invasion (2003) (97)
RanBPM, a Nuclear Protein That Interacts with and Regulates Transcriptional Activity of Androgen Receptor and Glucocorticoid Receptor* (2002) (96)
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. (2006) (94)
Circulating tumour cells in metastatic head and neck cancers (2015) (89)
miRPlant: an integrated tool for identification of plant miRNA from RNA sequencing data (2014) (87)
Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population (2010) (85)
Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. (2001) (85)
Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment (2012) (83)
Epigenetic Mechanisms for Progression of Prostate Cancer (1998) (79)
Molecular Analysis of the Multiple GroEL Proteins of Chlamydiae (2003) (77)
Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene. (2003) (76)
Differential Regulation of Clusterin and Its Isoforms by Androgens in Prostate Cells* (2007) (76)
Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior (2014) (74)
Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention (2014) (74)
Two Classes of Androgen Receptor Elements Mediate Cooperativity through Allosteric Interactions* (2001) (69)
Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model (2010) (69)
Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer (2011) (69)
Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle (2013) (68)
The p38 mitogen‐activated protein kinase regulates interleukin‐1β‐induced IL‐8 expression via an effect on the IL‐8 promoter in intestinal epithelial cells (2003) (68)
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology (2017) (65)
A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome (2018) (63)
Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer (2005) (61)
PD-L1 expressing circulating tumour cells in head and neck cancers (2017) (61)
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality (2017) (58)
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance (2010) (57)
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer (2016) (55)
Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis. (2014) (54)
Circulating tumor cell detection in high-risk non-metastatic prostate cancer (2014) (54)
Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts (2009) (54)
J-Circos: an interactive Circos plotter (2015) (51)
Osteopontin expression correlates with melanoma invasion. (2005) (51)
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer (2020) (51)
Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin‐6 expression (2009) (50)
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens (2006) (49)
A Collective Route to Head and Neck Cancer Metastasis (2018) (48)
Androgen‐mediated cholesterol metabolism in LNCaP and PC‐3 cell lines is regulated through two different isoforms of acyl‐coenzyme A: Cholesterol Acyltransferase (ACAT) (2008) (47)
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance (2017) (47)
Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis (2019) (46)
Apocryphal FADS2 activity promotes fatty acid diversification in cancer. (2021) (45)
Short term ex-vivo expansion of circulating head and neck tumour cells (2016) (45)
A liquid biopsy for head and neck cancers (2016) (44)
IGF2 increases de novo steroidogenesis in prostate cancer cells. (2013) (44)
P‐glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells (2004) (44)
The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells (2015) (42)
Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system. (2003) (42)
A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells. (2010) (39)
A novel communication role for CYP17A1 in the progression of castration‐resistant prostate cancer (2009) (38)
Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism* (2006) (38)
Cluster-based network model for time-course gene expression data. (2007) (37)
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors. (2007) (37)
Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines (2017) (37)
The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer (2015) (36)
A gene signature identified using a mouse model of androgen receptor‐dependent prostate cancer predicts biochemical relapse in human disease (2012) (36)
Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter (2006) (34)
Heterogeneity of miR-10b expression in circulating tumor cells (2015) (34)
Differential regulation of IGFBP‐3 by the androgen receptor in the lineage‐related androgen‐dependent LNCaP and androgen‐independent C4‐2 prostate cancer models (2006) (33)
Antiproliferative Mechanisms of the Flavonoids 2,2′-Dihydroxychalcone and Fisetin in Human Prostate Cancer Cells (2010) (33)
Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells (2007) (33)
Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer. (2003) (32)
Prostate‐tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter (2004) (31)
Microarray genotyping resource to determine population stratification in genetic association studies of complex disease. (2004) (31)
Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip. (2015) (30)
Adenovirus E1b-58 kD antigen binds to p53 during infection of rodent cells: evidence for an N-terminal binding site on p53. (1991) (30)
Transcriptomic analysis of mRNA expression and alternative splicing during mouse sex determination (2018) (30)
Impact of label-free technologies in head and neck cancer circulating tumour cells (2016) (30)
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer (2010) (29)
Characterization of an Androgen-Specific Response Region Within the 5′ Flanking Region of the Murine Epididymal Retinoic Acid Binding Protein Gene1 (2000) (28)
Androgen responsiveness of Renilla luciferase reporter vectors is promoter, transgene, and cell line dependent (2004) (27)
Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularis. (2016) (27)
An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression. (2004) (27)
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. (2016) (26)
Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop (2015) (25)
Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer (2017) (25)
Isolation, structure determination and cytotoxicity studies of tryptophan alkaloids from an Australian marine sponge Hyrtios sp. (2014) (25)
RNASeqBrowser: A genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracks (2015) (24)
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells (2014) (24)
Artificial Neural Network Analysis of DNA Microarray-based Prostate Cancer Recurrence (2005) (23)
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours. (2017) (23)
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment (2019) (23)
New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication (2013) (23)
From Bench to Bedside: Immunotherapy for Prostate Cancer (2014) (22)
Probasin promoter assembles into a strongly positioned nucleosome that permits androgen receptor binding (2007) (22)
Relationship between P-box Amino Acid Sequence and DNA Binding Specificity of the Thyroid Hormone Receptor. (1995) (21)
Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer (2009) (21)
Cytotoxic C20 Diterpenoid Alkaloids from the Australian Endemic Rainforest Plant Anopterus macleayanus. (2015) (21)
mCOPA: analysis of heterogeneous features in cancer expression data (2012) (20)
A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53 (2002) (20)
The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells (2015) (20)
Retinoid X Receptor Alters the Determination of DNA Binding Specificity by the P-box Amino Acids of the Thyroid Hormone Receptor* (1996) (20)
Identification and characterization of a prostate-specific androgen-independent protein-binding site in the probasin promoter. (2003) (19)
Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion (2016) (19)
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer (2014) (19)
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides. (2015) (19)
Identification of Eusynstyelamide B as a Potent Cell Cycle Inhibitor Following the Generation and Screening of an Ascidian-Derived Extract Library Using a Real Time Cell Analyzer (2014) (19)
Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer. (2012) (19)
Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer (2014) (18)
The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer (2012) (18)
E1a revisited: the case for multiple cooperative trans-activation domains. (1991) (18)
PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer (2014) (18)
Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2 (2019) (18)
Differential Expression and Network Inferences through Functional Data Modeling (2009) (17)
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer (2016) (16)
Fusion transcript loci share many genomic features with non-fusion loci (2015) (16)
6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells (2016) (15)
Relationship between P-box Amino Acid Sequence and DNA Binding Specificity of the Thyroid Hormone Receptor. (1995) (14)
Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide (2017) (14)
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer (2020) (14)
The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth (2019) (13)
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. (2015) (13)
Clusterin Facilitates COMMD 1 and I-κ B Degradation to Enhance NF-κ B Activity in Prostate Cancer Cells (2010) (13)
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness (2017) (12)
Demonstration of Upregulated H2 Relaxin mRNA Expression during Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells and Production of Biologically Active Mammalian Recombinant 6 Histidine‐Tagged H2 Relaxin (2005) (12)
Gene expression based inference of cancer drug sensitivity (2022) (12)
Insights from engraftable immunodeficient mouse models of hyperinsulinaemia (2017) (12)
Adiponectin receptor activation inhibits prostate cancer xenograft growth. (2020) (11)
Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1) (2020) (11)
Enhancement of biological effectiveness of radiotherapy treatments of prostate cancer cells in vitro using gold nanoparticles (2011) (11)
Acrylamide capture of DNA-bound complexes: electrophoretic purification of transcription factors. (2002) (11)
The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer (2019) (10)
Receptor-DNA interactions: EMSA and footprinting. (2009) (10)
Seed-Based Biclustering of Gene Expression Data (2012) (10)
IGF 2 increases de novo steroidogenesis in prostate cancer cells (2013) (10)
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer (2021) (9)
Application of gene microarrays in the study of prostate cancer. (2003) (9)
Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells (2017) (9)
E1a-dependent expression of adenovirus genes in OTF963 embryonal carcinoma cells: role of E1a-induced differentiation. (1990) (8)
Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging. (2020) (8)
Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells. (2008) (7)
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid. (2015) (7)
Improving self-care of patients with chronic disease using online personal health record. (2012) (7)
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer. (2015) (7)
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation (2022) (7)
Design, synthesis and spectroscopic characterisation of a focused library based on the polyandrocarpamine natural product scaffold (2013) (6)
Intraprostatic steroidogenic enzymes - letter. (2010) (6)
Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells. (2018) (6)
568 PSMA pet improves diagnostic accuracy of mpMRI in localised prostate cancer as confirmed by whole mount histopathology: Implications for selection and assessment for active surveillance and focal therapy (2016) (6)
Transient Sox9 Expression Facilitates Progression to Castrate Resistant Prostate Cancer. (2020) (6)
A variant of the KLK 4 gene is expressed as a cis sense – antisense chimeric transcript in prostate cancer cells (2010) (5)
Isomeric lipid signatures reveal compartmentalized fatty acid metabolism in cancer (2022) (5)
Mining human cancer datasets for kallikrein expression in cancer: the ‘KLK-CANMAP’ Shiny web tool (2018) (5)
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype (2019) (5)
Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys3]-GHRP-6 (2018) (4)
Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome (2018) (4)
Leptin antagonism inhibits prostate cancer xenograft growth and progression. (2021) (4)
Epithelial-mesenchymal axis in head and neck cancer cell lines (2015) (3)
Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth (2015) (3)
Erratum to: Fusion transcript loci share many genomic features with non-fusion loci (2016) (3)
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction (2018) (3)
Big data analytics in single‐cell transcriptomics: Five grand opportunities (2021) (3)
Transient Sox 9 Expression Facilitates Resistance to Androgen Targeted Therapy in 1 Prostate Cancer (2019) (3)
A Pilot Study on Understanding the Journey of Advanced Prostate Cancer Patients (2011) (3)
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer progression (2019) (2)
Gene expression changes during acquired resistance to tamoxifen and letrozole; a preclinical model of post-menopausal breast cancer (2005) (2)
Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901. (2014) (2)
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1) (2018) (1)
Gene expression changes during acquired resistance to tamoxifen; a preclinical model of post-menopausal breast cancer (2004) (1)
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. (2015) (1)
The ghrelin receptor antisense long non-coding RNA, GHSROS, in prostate cancer growth and survival (2015) (1)
P03-26 Insulin-like Growth Factor-II increases de novo steroidogenesis in prostate cancer cells (2012) (1)
Mediated Suppression of Apoptosis − Signal Transducers and Activators of Transcription 3 Androgen-Independent Progression in Prostate Cancer via Increased Hsp 27 after Androgen Ablation Facilitates (2005) (1)
Defective expression of adenovirus genes during early infection of undifferentiated OTF963 embryonal carcinoma cells (1990) (1)
Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines (2016) (1)
Adenovirus gene expression in F9 embryonal carcinoma cells (1990) (1)
ANovel Communication Role for CYP17A1in the Progression of Castration-Resistant Prostate Cancer (2009) (1)
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1) (2018) (1)
Identi fi cation of a novel fusion transcript between human relaxin-1 ( RLN 1 ) and human relaxin-2 ( RLN 2 ) in prostate cancer (2016) (1)
Androgen deprivation therapy induced rise in leptin level can be reduced with metformin: Results from ADMET trial [published abstract] (2017) (1)
Visualization of next generation sequencing data (2015) (1)
Abstract 4909: Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance (2017) (1)
Understanding requirements of novel healthcare information systems for management of advanced prostate cancer (2012) (1)
Molecular and Cellular Pathobiology Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression (2011) (1)
Profiling adaptive lipid metabolism in prostate cancer cells in response to androgen deprivation and hyperinsulinaemia (2016) (0)
Gene expression based inference of drug resistance in cancer (2021) (0)
572: Differential Regulation of IGFBP-3 by the Androgen Receptor in Progression to Androgen Independent Prostate Cancer (2005) (0)
Kallikrein Related Proteases and Wnt Pathway Interactions (2008) (0)
Biomarker and Translational Prostate Cancer Research (2015) (0)
Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion (2016) (0)
The lncRNA GHSROS mediates tumour growth and expression of genes associated (2017) (0)
A Collective Route to Head and Neck Cancer Metastasis (2018) (0)
Abstract B11: Using three-dimensional (3-D) culture systems to delineate the role of RANKL in metastatic prostate cancer (2013) (0)
Discovery of a prostate-specific gene and a tumor-specific gene expressed in prostate cancer by digital differential display combined with experimental expression analysis (2005) (0)
Current trends in prostate cancer treatment and drug resistance (2014) (0)
Differential Regulation of Clusterin Isoforms by the Androgen Receptor (2009) (0)
Kallikrein-related peptidase 4 induces tumour microenvironment alterations that support tumour growth (2015) (0)
Update on androgen deprivation therapy and adjuvant metformin (ADMET) trial for men with treatment naïve metastatic prostate cancer (2016) (0)
miRPlant: an integrated tool for identification of plant miRNA from RNA sequencing data (2014) (0)
Abstract 818: Unravelling the role of androgen targeted therapies in epithelial plasticity during prostate cancer progression (2017) (0)
Erratum to: Fusion transcript loci share many genomic features with non-fusion loci (2016) (0)
Androgen responsive non-coding RNA regulates the expression of prostate cancer associated CTBP1in LNCaP (2013) (0)
Abstract 1656: Evexomostat: A novel therapeutic in development for the treatment of prostate cancer (2023) (0)
Targeting metabolic dysfunction induced by ADT in advance prostate cancer (2017) (0)
Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis (2015) (0)
Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality (2017) (0)
Implicating Glucagon-like peptide-1 in the hormone-dependent metabolic reprogramming observed in advanced prostate cancer (2016) (0)
No effect of administration of unacylated ghrelin on subcutaneous PC3 xenograft growth in a Rag1−/− mouse model of metabolic dysfunction (2018) (0)
Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells (2017) (0)
Gene expression changes during acquired resistance to tamoxifen; a preclinical model of post-menopausal breast cancer. (2004) (0)
Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer (2015) (0)
1064 Delivery of precision medicine in advanced prostate cancer using circulating tumour cells (2016) (0)
255: Clusterin May Regulate NF-KB-Regulated Genes (2006) (0)
Modulation of protease expression in prostate cancer cells after androgen deprivation (2015) (0)
Genome analysis J-Circos: An Interactive Circos plotter (2017) (0)
507: The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin b8 in prostate cancer cells (2014) (0)
Translational Science (2016) (0)
1137: Antisense Inhibition of Clusterin Enhances Apoptotic Cell Death in Human Prostate Cancer Cells through not Only Down-Regulation of Anti-Apoptotic Clusterin Isoform but Up-Regulation of Pro-Apoptotic Clusterin Isoform (2007) (0)
Implicating the Glucagon-like peptides in the metabolic reprogramming observed in response to Androgen Deprivation Therapy in advanced prostate cancer: Presidential Poster prize finalist (2017) (0)
Characteristics cDNA Microarray : Data Mining and Interspecific Hybridization Development and Application of a Salmonid EST Database and (2004) (0)
Preclinical evidence that chemotherapy for prostate cancer should be given at the same time as androgen withdrawal (2005) (0)
More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer (2016) (0)
Prostate cancer metastasis, the noncanonical Wnt pathway, and the transcription factor PITX2. (2010) (0)
A prostate cancer risk associated polymorphism regulates androgen mediated regulation of a novel long noncoding RNA, IRX4lncRNA (2016) (0)
Abstract 2855: Monitoring tumor growth and oxygen distribution of prostate cancer xenograftsin vivousing ultrasound and photoacoustic imaging (2017) (0)
In vivo Knockdown of theAndrogen Receptor Results in Growth Inhibition and Regression of Well-Established , Castration-Resistant ProstateTumors (2008) (0)
Targeting the adaptive response in adiponectin receptor signalling following androgen targeted therapy in prostate cancer: Efficacy in castrate LNCaP tumour xenografts in vivo (2018) (0)
Abstract 5096: Alterations in cholesterol regulation contribute to the production of intratumoral androgens in castration-resistant prostate cancer (2010) (0)
481 CLUSTERIN IS A CRITICAL DOWNSTREAM MEDIATOR OF STRESS-INDUCED YB-1 TRANSACTIVATION IN PROSTATE CANCER (2012) (0)
Abstract 3421: Twist1 and clusterin regulate epithelial-mesenchymal transition (2011) (0)
DeepView: A genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracks (2015) (0)
Comparison of Psma Pet/ct, Psma Pet/mr and Multiparametric Mr in the Detection of Primary Prostate Cancer (2017) (0)
Leptin receptor antagonist, Allo-Aca, prevents migration, invasion and modifies lipogenesis pathways in prostate cells (2015) (0)
Analysis of gene expression influenced by EphB4 identifies integrin β 8 as simultaneously regulated in prostate cancer cells (2014) (0)
Editorial: Biomarker and translational prostate cancer research (2015) (0)
MP07-18 PERSISTENCE OF CIRCULATING TUMOUR CELLS (CTCS) IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY CAN BE USED TO ENRICH AND PROPAGATE TEMPORARY PERSONALIZED CELL LINES (2016) (0)
Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Clinical evaluation of prognostic and metabolic benefits of Metformin in prostate cancer (2015) (0)
Differentially androgen regulated genes in androgen dependent (LNCaP) and independent (C4-2) prostate cancer cells (2005) (0)
RNASeqBrowser: A genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracks (2015) (0)
Networks Discovery through Timing Maps (2007) (0)
Abstract 3442: The long non-coding RNAGHSROSmediates expression of genes associated with tumor growth, metastasis and adverse disease outcome (2017) (0)
Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in diagnosing localised prostate cancer (2015) (0)
924 The Ascidian Natural Product Eusynstyelamide B Induces G2/M Phase Arrest in Human Breast Cancer Cells (2012) (0)
500 USING THREE-DIMENSIONAL (3D) CULTURE SYSTEMS TO DELINEATE THE ROLE OF RANKL IN METASTATIC PROSTATE CANCER (2013) (0)
Androgen receptor and nutrient signaling pathways coordinate increased amino acid transport in prostate cancer progression (2012) (0)
Relaxin Regulates Migratory Potential Of Leukocytes Through A Lgr7-Dependent Signaling Pathway (2005) (0)
Abstract 2452: Dysregulated expression of the human long noncoding RNAGHSROSmay influence prostate cancer progression and resistance to docetaxel (2018) (0)
Targeting the role of YKL40 in metastatic prostate cancer (2014) (0)
Androgen influence on prostate cancer secreted microvesiclesproduction and content (2014) (0)
Latent representation of single-cell transcriptomes enables algebraic operations on cellular phenotypes (2022) (0)
Isomeric lipid signatures reveal compartmentalised fatty acid metabolism in cancer (2021) (0)
Insights from engraftable ��mouse models of hyperinsulinaemia (2017) (0)
Investigating the role of neuroendocrine transdifferentiation in the progression to castration resistant prostate cancer (2015) (0)
Investigation of deregulated lipid metabolism in advanced prostate cancer (2015) (0)
Androgen-stimulated extracellular vesicles regulate cellular proliferation in androgen deprived prostate cancer cells (2015) (0)
Metabolic plasticity in cancer activates apocryphal pathways for lipid desaturation (2020) (0)
Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer (2020) (0)
Title: Insulin increases de novo steroidogenesis in prostate cancer cells Running title: Insulin increases steroidogenesis in prostate cancer cells (2011) (0)
Fusion transcript loci share many genomic features with non-fusion loci (2015) (0)
PD-L1 expressing circulating tumour cells in head and neck cancers (2017) (0)
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer (2023) (0)
Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer (Conference Abstract) (2015) (0)
NOVEL IN VITRO ORGANOID TECHNOLOGY TO FACILITATE A PRECISION MEDICINE APPROACH IN THE MANAGEMENT OF MEN WITH BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: PNFBA‐08 (2017) (0)
Investigating the epithelial to mesenchymal transition in prostate cancer invasion and metastasis (2013) (0)
554 INCREMENTAL EXPRESSION OF PITX2, A WNT PATHWAY ASSOCIATED TRANSCRIPTION FACTOR IN PRIMARY AND METASTATIC PROSTATE CANCER (2010) (0)
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation (2022) (0)
Characterisation of novel primary tumour derived epithelial prostate cancer cell lines (2015) (0)
KALLIKREIN RELATED PROTEASES AND WNT PATHWAY INTERACTIONS IN PROSTATE CANCER (2008) (0)
Inhibition of fatty acid synthase suppresses androgen signaling in LNCaP cells (2014) (0)
Insulin increases apoptotic resistance in prostate cancer cells, but are sensitised by metformin (2015) (0)
Insights from engraftable immunodeficient mouse models of hyperinsulinaemia (2017) (0)
Enrichment and propagation of circulating tumour cells in men with hormone naive metastatic prostate cancer (Conference Abstract) (2015) (0)
Targeting epithelial-mesenchymal plasticity for improved treatments of advanced prostate cancer (2013) (0)
Toward Revealing the Complexity of Androgen-Responsive Protein and Noncoding Transcripts in Prostate Cancer (2013) (0)
PTEN (phosphatase and tensin homologue deleted on chromosome 10) gain-of-function analysis in LNCaP prostate cancer cells (2005) (0)
YB-1, a key regulator of androgen receptor signaling (2015) (0)
Of protein (IGFBP) -2-oligodeoxynucleotides to treat prostate cancer (2001) (0)
The mesenchymal-to-epithelial reverting transition is enriched in metastatic castration resistant prostate cancer and correlates with poor survival (2015) (0)
Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back (2012) (0)
Abstract 5572: Circulating tumor cells: The tumor trail left in the blood (2018) (0)
Androgen influence on prostate cancer exosomes production and content (2013) (0)
Glypican-1: A new biomarker for the detection of prostate cancer (2016) (0)
Isomer-resolved lipidomics for analysis of human prostate tumours and cancer cell lines (2020) (0)
A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness (2017) (0)
Correction: Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment (2013) (0)
The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells (2015) (0)
Complexity of androgen action in prostate cancer progression (2012) (0)
278: The kallikrein-related serine peptidase, KLK4, regulates the TGFb1 pathway in the tumour–stroma microenvironment in prostate cancer (2014) (0)
Antisense therapy against TRPM-2. (2000) (0)
Identification of novel androgen and antiandrogen regulated long noncoding RNAs and protein-coding RNAs in prostate cancer (2013) (0)
A Multiple Nucleotide Length Polymorphism (MNLP) mediates androgen regulation of IRX4 in prostate cancer (2015) (0)
Analysis of differential gene expression based on Bayesian estimation of variance (2016) (0)

This paper list is powered by the following services:

Other Resources About Colleen Nelson

en.wikipedia.org

What Schools Are Affiliated With Colleen Nelson?

Colleen Nelson is affiliated with the following schools:

Colleen Nelson's Academic­Influence.com Rankings